Leemans, C. René
Snijders, Peter J. F.
Brakenhoff, Ruud H.
Article History
First Online: 2 March 2018
Competing interests
: R.H.B has a longstanding collaboration with and receives support from InteRNA Technologies BV and received support from Agilent Technologies Netherlands BV and AbbVie. C.R.L has a collaboration with and receives support from Genmab and InteRNA Technologies BV. C.R.L. also participates in the advisory boards of Merck and MSD. P.J.F.S. is a minority stakeholder and the Chief Science Officer of Self-Screen BV, a spin-off company of VU University Medical Center. P.J.F.S. has been on the Speaker Bureau of Roche Diagnostics, Gen-Probe, Abbott, Qiagen and Seegene and has been a consultant for Crucell BV.